Hospira Optimizes Current Selection of Infusion Pump Device with Two Groundbreaking Technologies

August 22, 2014

August 22, 2014

Hospira announced that the plan to upgrade its spectrum of medical device offerings in May, 2013 is midway towards completion. To jumpstart product inventory optimization, Hospira applied for the Food and Drug Administration (FDA) Premarket Notification 510(k) Submission process for two of their revolutionary next-generation infusion pump systems: the Plum 360 and the SapphirePlus.

Hospira Optimizes Current Selection of Infusion Pump Device with Two Groundbreaking Technologies

Prior to this 510(k) submission, Hospira received a number of warning letters from the FDA regarding the issues on their manufacturing facilities. In compliance with this set of safety standards, Hospira had developed a comprehensive remediation strategic plan encompassing the modifications of their research and development facilities; the software, IV sets and infusion pumps development protocols; the finished products; as well as the changes in capital and operating expenditures.

Hospira gained 25% of the $2 billion IV pump market net sales, giving about a 25% market share. The company also reported an estimated $215.5 million in medication management net sales for the second quarter, including infusion pumps, IV kits, and equipment software. This rating showed an increased growth in the company’s net sales to $1.1 billion for that quarter.

With the continuous effort to expand its geographical footprint, customer base, and product development segment, Hospira steadfastly positioned itself to deliver innovatively designed injectable pharmaceutical drugs and clinical infusion technologies for hospitals and healthcare facilities across the globe. These substantial investments also help boost customer confidence on their product as they continue to meet the increasing demands on medical technology strategy, quality, and consistency.

Clinical-grade and advanced infusion therapy solutions like Hospira’s Plum 360 and the SapphirePlus innovations could play a pivotal role in ensuring the precise, safe, and reliable fluid and/or drug administration to patients with condition requiring intravenous type of medications. AIV offers a wide range of hospital-grade refurbished infusion pumps, replacement parts, and accessories that meet quality control and safety standards. Learn more about AIV’s selection of IV pump products and expert solutions at www.aiv-inc.com/iv-infusion-pump-replacement-parts.html today for more information.

About the Author

Laura Collier

Laura Collier

Laura Collier has a Bachelor’s Degree in Communications and a Master’s Degree in Business Administration from the University of North Florida. She is the Marketing Manager at AIV, Inc.

AIV Catalog

Request Your Printed or Electronic Copy Today!
We Respect Your Privacy

Be Part of Our
Biomed Community

Healthcare technology management professionals are a vital link in hospital operations, and we proudly support the national, state, and local associations with ongoing support and resources.

Get Biomed Resources

Why buy from AIV

AIV strives to provide you cost effective options to service equipment. We offer flexible solutions to best suit your needs.